268 related articles for article (PubMed ID: 34726252)
1. [Retracted] Silencing XIAP suppresses osteosarcoma cell growth, and enhances the sensitivity of osteosarcoma cells to doxorubicin and cisplatin.
Qu Y; Xia P; Zhang S; Pan S; Zhao J
Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34726252
[TBL] [Abstract][Full Text] [Related]
2. [Retracted] Synergistic growth inhibition by sorafenib and cisplatin in human osteosarcoma cells.
Yang Q; Zhang S; Kang M; Dong R; Zhao J
Oncol Rep; 2021 Sep; 46(3):. PubMed ID: 34278510
[TBL] [Abstract][Full Text] [Related]
3. [Retracted] Silencing NOB1 enhances doxorubicin antitumor activity of the papillary thyroid carcinoma
Liu J; Dong BF; Wang PS; Ren PY; Xue S; Zhang XN; Han Z; Chen G
Oncol Rep; 2022 May; 47(5):. PubMed ID: 35234269
[TBL] [Abstract][Full Text] [Related]
4. [Retracted] MicroRNA‑154 functions as a tumor suppressor in osteosarcoma by targeting Wnt5a.
Zhou H; Zhang M; Yuan H; Zheng W; Meng C; Zhao D
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34278509
[TBL] [Abstract][Full Text] [Related]
5. [Retracted] Oncolytic adenovirus‑mediated mda‑7/IL‑24 expression suppresses osteosarcoma growth and enhances sensitivity to doxorubicin.
Liu Z; Xu L; Yuan H; Zhang Y; Zhang X; Zhao D
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34608497
[TBL] [Abstract][Full Text] [Related]
6. [Retracted] miR‑218 suppresses tumor growth and enhances the chemosensitivity of esophageal squamous cell carcinoma to cisplatin.
Tian H; Hou L; Xiong YM; Huang JX; She YJ; Bi XB; Song XR
Oncol Rep; 2022 Mar; 47(3):. PubMed ID: 35039879
[TBL] [Abstract][Full Text] [Related]
7. [Retracted] miR‑222 regulates sorafenib resistance and enhance tumorigenicity in hepatocellular carcinoma.
Liu K; Liu S; Zhang W; Ji B; Wang Y; Liu Y
Int J Oncol; 2021 Dec; 59(6):. PubMed ID: 34726253
[TBL] [Abstract][Full Text] [Related]
8. [Retracted] MicroRNA-124 suppresses the migration and invasion of osteosarcoma cells via targeting ROR2-mediated non-canonical Wnt signaling.
Zhang C; Hu Y; Wan J; He H
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34109991
[TBL] [Abstract][Full Text] [Related]
9. [Retracted] MicroRNA-205 acts as a tumor suppressor in osteosarcoma via targeting RUNX2.
Zhang C; Long F; Wan J; Hu Y; He H
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34109990
[TBL] [Abstract][Full Text] [Related]
10. [Retracted] Small interfering RNA‑induced silencing of galectin‑3 inhibits the malignant phenotypes of osteosarcoma
Lei P; He H; Hu Y; Liao Z
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34296294
[TBL] [Abstract][Full Text] [Related]
11. [Retracted] miR‑133a inhibits cervical cancer growth by targeting EGFR.
Song X; Shi B; Huang K; Zhang W
Oncol Rep; 2021 Jul; 46(2):. PubMed ID: 34080664
[TBL] [Abstract][Full Text] [Related]
12. [Retracted] MicroRNA‑874 inhibits growth, induces apoptosis and reverses chemoresistance in colorectal cancer by targeting X‑linked inhibitor of apoptosis protein.
Han J; Liu Z; Wang N; Pan W
Oncol Rep; 2022 Apr; 47(4):. PubMed ID: 35137925
[TBL] [Abstract][Full Text] [Related]
13. [Retracted] Knockdown of CREB1 inhibits tumor growth of human gastric cancer
Rao M; Zhu Y; Cong X; Li Q
Oncol Rep; 2021 Dec; 46(6):. PubMed ID: 34617576
[TBL] [Abstract][Full Text] [Related]
14. [Retracted] miR‑137 acts as a tumor suppressor in papillary thyroid carcinoma by targeting CXCL12.
Dong S; Jin M; Li Y; Ren P; Liu J
Oncol Rep; 2021 Sep; 46(3):. PubMed ID: 34318908
[TBL] [Abstract][Full Text] [Related]
15. [Retracted] Synthetic miR‑145 mimic inhibits multiple myeloma cell growth
Zhang Q; Yan W; Bai Y; Xu H; Fu C; Zheng W; Zhu Y; Ma J
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34184081
[TBL] [Abstract][Full Text] [Related]
16. [Retracted] miR‑494 promotes cell proliferation, migration and invasion, and increased sorafenib resistance in hepatocellular carcinoma by targeting PTEN.
Liu K; Liu S; Zhang W; Jia B; Tan L; Jin Z; Liu Y
Oncol Rep; 2022 Feb; 47(2):. PubMed ID: 34850964
[TBL] [Abstract][Full Text] [Related]
17. [Retracted] miR-126 inhibits papillary thyroid carcinoma growth by targeting LRP6.
Wen Q; Zhao J; Bai L; Wang T; Zhang H; Ma Q
Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34080656
[TBL] [Abstract][Full Text] [Related]
18. [Retracted] miR‑363 inhibits the growth, migration and invasion of hepatocellular carcinoma cells by regulating E2F3.
Ye J; Zhang W; Liu S; Liu Y; Liu K
Oncol Rep; 2021 Nov; 46(5):. PubMed ID: 34498717
[TBL] [Abstract][Full Text] [Related]
19. [Retracted] MicroRNA‑128 suppresses cell growth and metastasis in colorectal carcinoma by targeting IRS1.
Wu L; Shi B; Huang K; Fan G
Oncol Rep; 2021 Sep; 46(3):. PubMed ID: 34278481
[TBL] [Abstract][Full Text] [Related]
20. [Retracted] miR‑124 inhibits proliferation and invasion of human retinoblastoma cells by targeting STAT3.
Liu S; Hu C; Wang Y; Shi G; Li Y; Wu H
Oncol Rep; 2021 Nov; 46(5):. PubMed ID: 34558651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
